DRG uses cookies to improve your experience on this website. Some of the cookies we use are essential for parts of the website to operate. Please be aware that if you continue without changing your cookie settings, you consent to this. For more information on our use of cookies, please review our cookie policy.

Healthcare Implications of 2016 U.S. Election

Roy Moore, DRG’s Principal Director of Global Market Access Insights, presents an overview of the healthcare effects of the 2016 U.S. election. Joined by industry analysts focused on various aspects of the healthcare ecosystem, Roy examines the implications of Republican control of national healthcare policy for the first time in a decade. Touching on the potential impact for the pharmaceutical and medical device industries, DRG experts share their assessment of what shifting policies may mean for the industry.